Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 21.48 USD 1.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Catalyst Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one CPRX stock under the Base Case scenario is 17.58 USD. Compared to the current market price of 21.48 USD, Catalyst Pharmaceuticals Inc is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CPRX Relative Value
Base Case
17.58 USD
Overvaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
64
Median 3Y
4.9
Median 5Y
4.6
Industry
7.7
Forward
5.2
vs History
4
vs Industry
6
Median 3Y
20.1
Median 5Y
17.4
Industry
22.7
Forward
18
vs History
23
vs Industry
11
Median 3Y
12.2
Median 5Y
11.8
Industry
21.6
vs History
25
vs Industry
9
Median 3Y
12.2
Median 5Y
12
Industry
25.2
vs History
33
vs Industry
26
Median 3Y
3.9
Median 5Y
3.9
Industry
2.5
vs History
19
vs Industry
57
Median 3Y
4.2
Median 5Y
3.6
Industry
7.7
Forward
4.4
vs History
19
vs Industry
56
Median 3Y
4.9
Median 5Y
4.3
Industry
9
vs History
4
vs Industry
8
Median 3Y
12.6
Median 5Y
10.7
Industry
4.2
Forward
10.4
vs History
4
vs Industry
6
Median 3Y
13.7
Median 5Y
10.7
Industry
4.1
Forward
12
vs History
14
vs Industry
12
Median 3Y
10.1
Median 5Y
9.8
Industry
5.7
vs History
14
vs Industry
9
Median 3Y
10.3
Median 5Y
9.8
Industry
3.6
vs History
53
vs Industry
30
Median 3Y
6.6
Median 5Y
8.4
Industry
4.6

Multiples Across Competitors

CPRX Competitors Multiples
Catalyst Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
2.5B USD 5.9 36.9 17.4 25.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
US
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Average P/E: 179.7
36.9
211%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Average EV/EBITDA: 17.2
17.4
109%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Average EV/EBIT: 22.9
25.3
212%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top